Found 5 matching trials
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers PHASE2 Background:
Gastrointestinal tumors have a molecule called carbohydrate an...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Study of a New Technique for Imaging Pancreatic Cancer PHASE1 The purpose of this study is to see how well the experimental imaging agent...
Show More Location
Memorial Sloan Kettering Basking Ridge (Consent only)
Learn More & Join Trial
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies PHASE1 Phase 1 Safety and Tolerability Study in Subjects with Pancreatic Cancer or...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy PHASE1 Open label, nonrandomized, dose-escalation with cohort expansion study of M...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1 PHASE1 Open label, nonrandomized, dose-escalation trial of MVT-2163 and MVT-5873 u...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial